Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gallbladder Neoplasms × regorafenib × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 5 Sarcoma 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Liver Metastasis Colon Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Gemcitabine 4 Cisplatin 4 pembrolizumab 3 durvalumab 2 Oxaliplatin 2 Capecitabine 2 zanidatamab 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tivozanib 1 fludarabine 1 atezolizumab 1 aldesleukin 1 Trastuzumab 1 Tegafur 1 Taxes 1 Specimen Handling 1 S 1 (combination) 1 Platinum 1 Observation 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Ipilimumab 1 Interleukin-2 1 Fluorouracil 1 Cyclophosphamide 1 CTLA-4 Antigen 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡